Visit us at CPhI Worldwide 2007 at Fiera di Milano, Italy, October 2-4 2007, "at Hall 14, Stand No: 14H09"

     APIs

  Commercial Scale
  Alendronate sodium
  Arteether
  Artemether
  Artesunate
  Azithromycin
  Cetirizine dihydrochloride
  Chloramphenicol palmitate
  Clopidogrel bisulphate
  Coenzyme Q10
  Dihydroartemisinin
  Erythromycin base
  Erythromycin estolate
  Erythromycin ethyl succinate
  Erythromycin oxime (intermediate)
  Erythromycin phosphate
  Erythromycin propionate
  Erythromycin stearate
  Isoniazid
  Lisinopril dihydrate
  Losartan potassium
  Pyrazinamide
  Rifampicin
  Roxithromycin
  Sodium valproate
  Valproic acid
  Venlafaxine hydrochloride
  Zoledronic acid
  Zopiclone

  Pilot Plant Scale
  Carvedilol
  Clarithromycin
  Pioglitazone hydrochloride
  Rosiglitazone maleate
  Valsartan

  R & D Scale

  Lumefantrine
  Pamidronate disodium
  Perindopril erbumine
  Zolpidem tartrate

  Development
  Benazepril hydrochloride
  Candesartan
  Desvenlafaxine
  Glipizide
  Irbesartan
  Levocetirizine
  Rifabutin
  Rifapentine
  Ramipril
  Risedronic acid
  Telmisartan
 

   Products under patent offered only
   for exempted research, clinical and
   development purposes. Only  non- 
   infringing products and processes 
   are offered, subject to patent  status    verification by client.

    Services
  • Custom Syntheses
  • Contract Manufacturing
  • FTE Research
  • Analytical Support
  • Intermediates & APIs
  • Building Blocks
 


Participation of Calyx at US Conferences


   Dr. Bharat Shah, President - Business Development and   Sales (CRO/CRAMS)
   for Calyx North America   Operation, will  give a   workshop  on "Pharmaceutical    Outsourcing-101" in  the Pharma  ChemOutsourcing Conference  to be  held
   at New Jersey, 9 - 11 September 2007

   Dr. Bharat Shah will be coordinating an interactive workshop on "Pharmaceutical    Outsourcing - What is the Asia factor in year 2007 and beyond?" in  the  Global      Pharma Manufacturing Summit at Chicago,
19 - 20 September 2007.
 


  
    
Research & Development - R&D Facility
Achievements

One Custom  Synthesis  project presenting  challenge  in terms  of   undesired   halogen  exchange  during reaction was    successfully   completed   at lab   scale.  Alternate methodology  was used  to  circumvent  the  problem and obtain desired product of right quality.

A Custom Synthesis query  was handled on  fast track to submit  few   grams   sample   within   two    weeks.  The samples are  approved  by  the  customer   and  now  the project   enters  a  phase  where  commercial  terms  are negotiated.


      


Calyx : Core Competencies      

Chemistry Technology
  • Pyrazines
  • Benzimidazoles
  • Pyrrolopyrazines
  • Hydrazide chemistry
  • Azide chemistry (Tetrazoles)
  • Catalytic hydrogenation
  • Borohydride reduction
  • Hofmann rearrangement
  • Halogenation (Bromination & Iodination)
  • Cryogenic reactions
  • Sonocrystallization and Sonochemistry
  • Continuous Stirred Reactor (CSTR)
  • Process stimulation through Aspentech Batch Plus software
                                                                                      click here for Reaction Capabilities



Blood Pressure Drugs Cut Death Rate in Diabetes

Perindopril is an angiotensin converting enzyme (ACE) inhibitor and Indapamide is a thiazide-like diuretic. The fixed combination of perindopril and indapamide is marketed in 97 countries worldwide. 
                                                                                                                              
                                                                                                    Read Full Article


Disclaimer:
"The information in this e-mail and any attachments is confidential and may be legally privileged. It is intended s olely for the addressee or addressees. If you are not an intended recipient, please delete the message and any attachments and notify the  sender of  misdelivery. Any  use or disclosure of  the  contents of either is unauthorized  and  may   be unlawful. All  liability  for viruses is  excluded to the fullest  extent permitted by law. Any views expressed in this message  are those of the individual sender, except where the sender   states them, with requisite authority, to be those of the specific Calyx company."

To unsubscribe from this Newsletter send blank email to pharmanews@calyxindia.com